Fissolo, N., Pignolet, B., Rio, J., Vermersch, P., Ruet, A., deSèze, J., . . . Comabella, M. (2021). Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. Neurol Neuroimmunol Neuroinflamm.
Citação norma ChicagoFissolo, Nicolás, et al. "Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab." Neurol Neuroimmunol Neuroinflamm 2021.
Citação norma MLAFissolo, Nicolás, et al. "Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab." Neurol Neuroimmunol Neuroinflamm 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.